76 related articles for article (PubMed ID: 3821181)
1. Breast cancer in residents of Rochester, Minnesota: incidence and survival, 1935 to 1982.
Ballard-Barbash R; Griffin MR; Wold LE; O'Fallon WM
Mayo Clin Proc; 1987 Mar; 62(3):192-8. PubMed ID: 3821181
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer incidence, prevalence, mortality, and survivorship in Rochester, Minnesota, 1935 to 1974.
Brian DD; Melton LJ; Goellner JR; Williams RL; O'Fallon WM
Mayo Clin Proc; 1980 Jun; 55(6):355-9. PubMed ID: 7382542
[TBL] [Abstract][Full Text] [Related]
3. Urban-rural differential in breast cancer incidence and mortality in Olmsted County, Minnesota, 1935-1974.
Melton LJ; Brian DD; Williams RL
Int J Epidemiol; 1980 Jun; 9(2):155-8. PubMed ID: 7409967
[TBL] [Abstract][Full Text] [Related]
4. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
5. Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands.
Ruiterkamp J; Ernst MF; de Munck L; van der Heiden-van der Loo M; Bastiaannet E; van de Poll-Franse LV; Bosscha K; Tjan-Heijnen VC; Voogd AC
Breast Cancer Res Treat; 2011 Jul; 128(2):495-503. PubMed ID: 21240629
[TBL] [Abstract][Full Text] [Related]
6. Decline in the overall incidence of regional-distant prostate cancer in Olmsted County, MN, 1980-2000.
Mullan RJ; Jacobsen SJ; Bergstralh EJ; Slezak JM; Tindall DJ; Lieber MM; Roberts RO
BJU Int; 2005 May; 95(7):951-5. PubMed ID: 15839911
[TBL] [Abstract][Full Text] [Related]
7. Benign breast lesions and subsequent breast carcinoma in Rochester, Minnesota.
Donnelly PK; Baker KW; Carney JA; O'Fallon WM
Mayo Clin Proc; 1975 Nov; 50(11):650-6. PubMed ID: 1186296
[TBL] [Abstract][Full Text] [Related]
8. Recent trends in U.S. breast cancer incidence, survival, and mortality rates.
Chu KC; Tarone RE; Kessler LG; Ries LA; Hankey BF; Miller BA; Edwards BK
J Natl Cancer Inst; 1996 Nov; 88(21):1571-9. PubMed ID: 8901855
[TBL] [Abstract][Full Text] [Related]
9. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009.
Johnson RH; Chien FL; Bleyer A
JAMA; 2013 Feb; 309(8):800-5. PubMed ID: 23443443
[TBL] [Abstract][Full Text] [Related]
10. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
12. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
13. Incidence and kinetics of distant metastases in patients with operable breast cancer.
Kryj M; Maciejewski B; Withers HR; Taylor JM
Neoplasma; 1997; 44(1):3-11. PubMed ID: 9201274
[TBL] [Abstract][Full Text] [Related]
14. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy.
Harris EE; Hwang WT; Seyednejad F; Solin LJ
Cancer; 2003 Nov; 98(10):2144-51. PubMed ID: 14601083
[TBL] [Abstract][Full Text] [Related]
15. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome following breast-conserving surgery and radiation therapy.
Gage I; Recht A; Gelman R; Nixon AJ; Silver B; Bornstein BA; Harris JR
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):245-51. PubMed ID: 7673011
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
19. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
[TBL] [Abstract][Full Text] [Related]
20. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma.
Wang W; Yuan P; Wang J; Ma F; Zhang P; Li Q; Xu B
Tumori; 2014; 100(6):600-4. PubMed ID: 25688492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
